Welcome to Crene Biotechnology!
Login| 中文| English

+86-576-88205808

Cart(0)
HOME
ABOUT CRENE
PRODUCTS
NEW&EVENTS
CUSTOM SYNTHESIS
ORDER INFORMATION
CONTACT US
+ AII PRODUCTS
- Prostaglandins - Custom Synthesis - PARP Inhibitors - PI3K Inhibitors - FAK Inhibitors - AKT Inhibitors - C-Kit Inhibitors - VEGFR Inhibitors - c-Met Inhibitors - CDK Inhibitors - CYP17 Inhibitors - DNA/RNA Inhibitors - mTOR Inhibitors - SRC Inhibitors - Others
Product :

RKI-1313

RKI-1313 1342276-76-9
Size Price Stock Quantity
Get Quotation Now Add to Cart Bulk Inquiry
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
Product name：RKI-1313 Purity：98% min
CAS NO：1342276-76-9 Solubility：
Molecular Formula：C17H16N4O2S Package：Package according to customer requirements
Molecular Weight：340.400 Storage：Store at -20℃
Quality control
Remarks

RKI-1313 Negative control for RKI-1447 (GLXC-05200) which is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer.

References
1: Patel RA, Forinash KD, Pireddu R, Sun Y, Sun N, Martin MP, Schönbrunn E, Lawrence NJ, Sebti SM. RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer. Cancer Res. 2012 Oct 1;72(19):5025-34. doi: 10.1158/0008-5472.CAN-12-0954. PubMed PMID: 22846914; PubMed Central PMCID: PMC3463757.
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link：
Home| About Crene| Products| New&Events| Custom Synthesis| Order Information| Contact US

Copyright Copyright (C) 2018-2024 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China